Environmental Health Perspectives · 2015 · 62 citations · 30 references
MedicineEndocrinologyObstetricsMaternal-fetal MedicineReproductive EndocrinologyReproductive MedicineAmniotic Fluid AssessmentPerinatal Risk FactorsPregnancyPregnancy EndocrinologyPrenatal AssessmentPrenatal Risk AssessmentAndrogen Levels In PregnancyBiochemical Biomarker ScreeningFetal Exposure AssessmentLeydig Cell SteroidogenesisReproductive Outcome AssessmentReproductive Tract Health
BACKGROUND: Exposure to perfluorooctane sulfonate (PFOS) may potentially disturb fetal Leydig cell hormone production and male genital development. OBJECTIVES: We aimed to study the associations between levels of amniotic fluid PFOS, fetal steroid hormone, and insulin-like factor 3 (INSL3) and the prevalence of cryptorchidism and hypospadias. METHODS: Using the Danish National Patient Registry, we selected 270 cryptorchidism cases, 75 hypospadias cases, and 300 controls with stored maternal amniotic fluid samples available in a Danish pregnancy-screening biobank (1980-1996). We used mass spectrometry to measure PFOS in amniotic fluid from 645 persons and steroid hormones in samples from 545 persons. INSL3 was measured by immunoassay from 475 persons. Associations between PFOS concentration in amniotic fluid, hormone levels, and genital malformations were assessed by confounder-adjusted linear and logistic regression. RESULTS: The highest tertile of PFOS exposure (> 1.4 ng/mL) in amniotic fluid was associated with a 40% (95% CI: -69, -11%) lower INSL3 level and an 18% (95% CI: 7, 29%) higher testosterone level compared with the lowest tertile (< 0.8 ng/mL). Amniotic fluid PFOS concentration was not associated with cryptorchidism or hypospadias. CONCLUSIONS: Environmental PFOS exposure was associated with steroid hormone and INSL3 concentrations in amniotic fluid, but was not associated with cryptorchidism or hypospadias in our study population. Additional studies are needed to determine whether associations with fetal hormone levels may have long-term implications for reproductive health. CITATION: Toft G, Jönsson BA, Bonde JP, Nørgaard-Pedersen B, Hougaard DM, Cohen A, Lindh CH, Ivell R, Anand-Ivell R, Lindhard MS. 2016. Perfluorooctane sulfonate concentrations in amniotic fluid, biomarkers of fetal Leydig cell function, and cryptorchidism and hypospadias in Danish boys (1980-1996). Environ Health Perspect 124:151-156; http://dx.doi.org/10.1289/ehp.1409288.
30
Geary W. Olsen, Jean M. Burris, David J. Ehresman et al. · Environmental Health Perspectives · 2007 · 2K citations · Full text
The Danish Civil Registration System. A cohort of eight million persons.
Carsten Bøcker Pedersen, Heine Gøtzsche, Jørgen Ostrup Møller et al. · PubMed · 2006 · 1.6K citations
The Danish Medical Birth Registry.
Knudsen Lb, Jesper Kenneth Olsen · PubMed · 1998 · 813 citations
Do Perfluoroalkyl Compounds Impair Human Semen Quality?
Ulla Nordström Joensen, Rossana Bossi, Henrik Leffers et al. · Environmental Health Perspectives · 2009 · 407 citations · Full text
Medicine, Endocrinology, Toxicology +17